TMCnet News

Research and Markets: Regenerative Medicine - Global Trends, Estimates and Forecasts, 2013-2019
[April 23, 2015]

Research and Markets: Regenerative Medicine - Global Trends, Estimates and Forecasts, 2013-2019


Research and Markets (http://www.researchandmarkets.com/research/rh6ppm/regenerative) has announced the addition of the "Regenerative Medicine - Global Trends, Estimates and Forecasts, 2013-2019" report to their offering.

Global Regenerative Medicine market is estimated to reach US$24.7 billion by 2017. Regenerative Medicine in Orthopedics market is projected to reach US$10.3 billion by 2017, growing at a CAGR of 12.2% for the analysis period 2013-2019 respectively.

Skin/Integumentary and Urology together account for approximately 25.97% (2016) of the market are expected to support the Regenerative Medicine Industry going forward. Geographical analysis for Regenerative Medicine in Cardiology shows that the highest Compounded Annual Growth Rate (CAGR) of 18.1% is anticipated from Asia-Pacific region during the analysis period 2013-2019.

The report Regenerative Medicine - Global Trends, Estimates and Forecasts, 2013-2019' reviews the latest rends in regenerative medicine with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments. The study reveals profitable investment strategies for market start-ups, pharmaceutical/biotechnology companies, laboratories, Contract/Clinical/Commercial Research Organizations (CROs), government/academic organizations, consulting firms, database buyers and many more in preferred locations.



Regenerative Medicine - Segmentation

  • Therapeutic Area
  • Orthopedics
  • Skin/Integumentary
  • Cardiology
  • Neurology
  • Urology
  • Other
  • Biological Substitutes
  • Cells and Biomaterials
  • Biomolecules
  • Manufacturing Factors and
  • Other

Companies Mentioned


The Americas

  • Cell2B (USA)
  • Angiocrine Bioscience (USA)
  • Platelet Biogenesis (USA)
  • Biomatrica, Inc (USA)
  • Athersys, Inc. (USA)
  • Cellular Dynamics International, Inc. (USA)
  • Tengion Inc (USA)
  • Vericel Corporation (USA)
  • Wright Medical Technology (USA)
  • Tissuegene, Inc. (USA)
  • Shire Regenerative Medicine (USA)
  • Regen Biopharma (Bio-Matrix Scientific Group) (USA)
  • Dsm Biomedical (USA)
  • Harvard Apparatus Regenerative Technology (USA)

Europe

  • Cellserve Gmbh (Germany)
  • Trakcel Ltd (United Kingdom)
  • Crispr Therapeutics (Switzerland)

Asia-Pacific

  • Cytori Therapeutics Inc (Japan)
  • Cyfuse Biomedical Kk (Japan)
  • Regenovo Biotechnology (China)
  • Cynata Therapeutics Limited (Australia)

For more information visit http://www.researchandmarkets.com/research/rh6ppm/regenerative


[ Back To TMCnet.com's Homepage ]